Delivery Order SPE2DB22D1103-SPE2DB24FTME1

Award Date 6/13/24
Potential Completion Date 6/14/24
Potential Value $2.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of one of the largest pharmaceutical distributors, is for the delivery of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The $1,451.40 firm-fixed-price delivery order has a completion date of June 25, 2024 and was awarded on June 24, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The award, valued at $2,902.80, is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) for the delivery of Trulicity 0.75 mg/0.5 ml pens. The Delivery Order, valued at $5,805.60, has a firm fixed price and an ultimate completion date of June 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $1,700.66, is for the delivery of Trulicity 1.5 mg/0.5 ml pens. This is a firm fixed-price delivery order contract with a completion date of May 14, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $2,947.26 firm fixed price delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pens. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Trulicity 0.75 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,621.85 and an ultimate completion date of July 5, 2024. It is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $3,483.36 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Trulicity 0.75 mg/0.5 ml pens. This contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. This award is part of a larger indefinite delivery contract (IDC) with a...
This federal contract award is for the delivery of Trulicity 3 mg/0.5 ml pens to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp. The contract, valued at $3,201.82, is a firm fixed-price delivery order with a completion date of June 7, 2024. The award is not associated with a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen Corporation, has a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the supply of the pharmaceutical product Trulicity 4.5 mg/0.5 ml pen 0.5ml. The contract, valued at $1,596.54, was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 18, 2024. The contract is a delivery order under a firm fixed-price arrangement, with no set-aside designation. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $1,479.90 firm fixed-price delivery order is for the supply of Trulicity 1.5 mg/0.5 ml pens. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTME1
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of Trulicity 1.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $2,237.56, is a Firm Fixed Price Delivery Order with a completion date of June 14, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 31, 2025, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The current award is not designated as a set-aside contract.

Generated 9/12/24, 12:32 PM